Svs Vision 07 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3184 Gratiot Blvd, Marysville, MI 48040 Phone: 810-364-5520 Fax: 810-364-6545 |
Patrick August Deview, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3160 Gratiot, Marysville, MI 48040 Phone: 810-364-5520 Fax: 810-364-6545 |
Thomas Woytta, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1100 Michigan Ave, Marysville, MI 48040 Phone: 810-364-1334 Fax: 810-364-1075 |
Dr. Mark John Sanitate, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3160 Gratiot Blvd, Marysville, MI 48040 Phone: 810-364-5520 Fax: 810-364-6545 |
Erica Gagnon, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3184 Gratiot Blvd, Marysville, MI 48040 Phone: 810-364-5520 |
Total Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 1100 Michigan Ave, Marysville, MI 48040 Phone: 810-364-1334 Fax: 810-364-1075 |
Julia Mobilio, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3184 Gratiot Blvd, Marysville, MI 48040 Phone: 810-364-5520 Fax: 810-364-6545 |
News Archive
Oncolytics Biotech Inc. today announced that the first patients have been treated in a Phase 1b study of pembrolizumab (KEYTRUDA) in combination with REOLYSIN (pelareorep) and chemotherapy in patients with advanced pancreatic adenocarcinoma (REO 024).
Talecris Biotherapeutics Holdings Corp. today announced that Talecris and Grifols S.A. have each received a request for additional information and documentary material, often referred to as a "Second Request," from the U.S. Federal Trade Commission (FTC) in connection with their proposed merger.
Patients with chronic kidney disease are commonly exposed to nocturnal hypoxia that may increase the rate of decline in kidney function, Canadian researchers report.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for large-joint reconstructive implants will grow moderately through 2016.
The National Institutes of Health has awarded more than $12 million to Cleveland Clinic researchers to study the critical link between gut microbial pathways and the development of cardiometabolic diseases.
› Verified 6 days ago